Proteomic screening for serum biomarkers for cervical cancer and their clinical significance

Yani Chen, Xiaofan Xiong, Yanfeng Wang, Junmei Zhao, Haiyan Shi, Huahua Zhang, Yu Wang, Yameng Wei, Wanjuan Xue, Jing Zhang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Background: The present study aimed to determine serum markers for cervical cancer (CC) and to provide valuable references for clinical diagnosis and treatment. Material/Methods: Serum samples were collected from age-matched healthy control women, and from female CC patients before and after surgery. Serum biomarkers were selected by comparing serum peptides profiles among the 3 groups by magnetic bead-based weak cation – exchange chromatography fractionation combined with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Probable serum biomarkers for cervical cancer were then further identified by liquid chromatography-electrospray ionization-tandem mass spectrometry system and the identified proteins were verified by enzyme-linked immunosorbent assay (ELISA). Results: Three peptide biomarkers were identified for distinguishing CC patients from normal individuals, and distinguishing preoperative CC patients from postoperative CC patients. Of these 3 identified protein peptide regions, 2 peptide regions – TKT (Peak 2, 2435.63 m/z, 499–524) and FGA (Peak 4, 2761.79 m/z, 603–629) – were identified as upregulated markers, and peptide region of APOA1 (Peak 9, 2575.3 m/z, 245–260) was identified as a downregulated biomarker in preoperative CC patients compared with healthy women. Conclusions: The present study provides a new method for identifying potential serum biomarkers for CC patients.

Original languageEnglish
Pages (from-to)288-297
Number of pages10
JournalMedical Science Monitor
Volume25
DOIs
Publication statusPublished - 2019
Externally publishedYes

Keywords

  • Biomarkers
  • Pharmacological
  • Proteomics
  • Uterine Cervical Neoplasms

Fingerprint

Dive into the research topics of 'Proteomic screening for serum biomarkers for cervical cancer and their clinical significance'. Together they form a unique fingerprint.

Cite this